المؤلفون: Steven Joniau, Camille Capone, Simon Chowdhury, L. Dearden, Hiroji Uemura, Boris Hadaschik, Suzy Van Sanden, Joris Diels, Stéphane Oudard

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Non-metastatic castration-resistant prostate cancer, ENZALUTAMIDE, NETWORK METAANALYSIS, Medizin, Darolutamide, Research & Experimental Medicine, Androgen deprivation therapy, chemistry.chemical_compound, Prostate cancer, Internal medicine, Apalutamide, MANAGEMENT, Humans, Medicine, Pharmacology (medical), Pharmacology & Pharmacy, Adverse effect, Original Research, Science & Technology, business.industry, Hazard ratio, Androgen Antagonists, Bayes Theorem, MEN, General Medicine, Odds ratio, medicine.disease, Prostatic Neoplasms, Castration-Resistant, Thiohydantoins, Medicine, Research & Experimental, Tolerability, chemistry, SURVIVAL, Pyrazoles, business, Life Sciences & Biomedicine

وصف الملف: Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af254e607a4c624d4d5a7b7bb4d6443Test
https://doi.org/10.1007/s12325-021-01885-6Test

المؤلفون: Philippe Lehert, Cassandra Szoeke

المصدر: Drugs in Context, Vol 9, Pp 1-13 (2020)
Drugs in Context

مصطلحات موضوعية: Cataplexy, Pitolisant, Excessive daytime sleepiness, narcolepsy, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, daytime wakefulness, mental disorders, Medicine, 030212 general & internal medicine, epworth sleepiness scale, Adverse effect, network meta-analysis, pitolisant, Original Research, Pharmacology, cataplexy, business.industry, Epworth Sleepiness Scale, lcsh:RM1-950, Modafinil, network metaanalysis, daytime sleepiness, General Medicine, medicine.disease, lcsh:Therapeutics. Pharmacology, chemistry, Anesthesia, Molecular Medicine, modafinil, medicine.symptom, business, 030217 neurology & neurosurgery, Narcolepsy, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b85b551038fa986f378854d11f620949Test
https://doi.org/10.7573/dic.2020-6-2Test

المؤلفون: Dominic Pilon, Jan Sermon, Stéphane Oudard, Joris Diels, Jinan Liu, L. Dearden, Hiroji Uemura, Kelly McQuarrie, Boris Hadaschik, Suzy Van Sanden, Steven Joniau, Simon Chowdhury, Patrick Lefebvre

مصطلحات موضوعية: Male, Health-related quality of life, NETWORK METAANALYSIS, Medizin, Research & Experimental Medicine, chemistry.chemical_compound, Prostate cancer, Quality of life, FUNCTIONAL ASSESSMENT, Apalutamide, Medicine, Pharmacology (medical), Pharmacology & Pharmacy, education.field_of_study, BONE METASTASES, MEN, General Medicine, Middle Aged, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Thiohydantoins, Tolerability, Medicine, Research & Experimental, Benzamides, Life Sciences & Biomedicine, medicine.medical_specialty, Non-metastatic castration-resistant prostate cancer, Population, Pain, Disease-Free Survival, Internal medicine, Nitriles, Phenylthiohydantoin, Androgen Receptor Antagonists, Enzalutamide, Humans, Adverse effect, education, Science & Technology, business.industry, Bayes Theorem, Odds ratio, Matching-adjusted indirect comparison, medicine.disease, chemistry, Adverse events, Quality of Life, business

وصف الملف: Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd6282459a47d5c02961d505eb4a21fTest
https://lirias.kuleuven.be/handle/20.500.12942/695066Test

المؤلفون: Laurent Peyrin-Biroulet, Anthony Lopez, Walter Reinisch, Alexander C. Ford, William J. Sandborn, Jean-Frederic Colombel

المساهمون: Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Hépato-gastro-entérologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds Institute of Biomedical & Clinical Sciences (LIBACS), University of Leeds, Division of Gastroenterology [Icahn], Icahn School of Medicine at Mount Sinai [New York] (MSSM), University Hospital Vienna, University of California [San Diego] (UC San Diego), University of California

المصدر: Digestive and Liver Disease
Digestive and Liver Disease, WB Saunders, 2015, 47 (5), pp.356-364. ⟨10.1016/j.dld.2015.01.148⟩

مصطلحات موضوعية: Risk, musculoskeletal diseases, medicine.medical_specialty, Moderate, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Anti-Inflammatory Agents, Golimumab, Inflammatory bowel disease, Gastroenterology, Placebos, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Network Metaanalysis, medicine, Adalimumab, Humans, Crohns-Disease, Intestinal Mucosa, skin and connective tissue diseases, Adverse effect, Colectomy, Clinical Trials as Topic, Hepatology, Tumor Necrosis Factor-alpha, business.industry, Remission Induction, Agents, medicine.disease, Ulcerative colitis, Infliximab, 3. Good health, Hospitalization, 030220 oncology & carcinogenesis, Randomized Clinical-Trials, Number needed to treat, Colitis, Ulcerative, 030211 gastroenterology & hepatology, Therapy, business, Inflammatory-Bowel-Disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8ca8007d56acbfd029ffcaecbc42cfTest
https://doi.org/10.1016/j.dld.2015.01.148Test